Lowe syndrome protein Ocrl1 is translocated to membrane ruffles upon Rac GTPase activation: a new perspective on Lowe syndrome pathophysiology
Open Access
- 13 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 14 (11), 1441-1448
- https://doi.org/10.1093/hmg/ddi153
Abstract
Oculocerebrorenal Lowe syndrome is a rare X-linked disorder characterized by bilateral cataract, mental retardation and renal Fanconi syndrome. The Lowe syndrome protein Ocrl1 is a PIP2 5-phosphatase, primarily localized to the trans-Golgi network (TGN), which ‘loss of function’ mutations result in PIP2 accumulation in patient's cells. Although PIP2 is involved in many cell functions including signalling, vesicle trafficking and actin polymerization, it has been difficult so far to decipher molecular/cellular mechanisms responsible for Lowe syndrome phenotype. We have recently shown that, through its C-terminal RhoGAP domain, Ocrl1 forms a stable complex with Rac GTPase within the cell. In line with this finding, we report here that upon epidermal growth factor induced Rac activation in COS-7 cells, a fraction of Ocrl1 translocates from TGN to plasma membrane and concentrates in membrane ruffles. In order to investigate the functionality of Ocrl1 in plasma membrane, we have analysed PIP2 distribution in human dermal fibroblasts (HDFs) from Lowe patients versus control HDFs. As revealed by both immunodetection and green fluorescent protein–PH binding, PIP2 was found strikingly to accumulate in PDGF induced ruffles in Lowe HDFs when compared with control. This suggests that Ocrl1 is active as a PIP2 5-phosphatase in Rac induced membrane ruffles. Cellular properties such as cell migration and establishment of cell–cell contacts, which depend on ruffling and lamellipodia formation, should be further investigated to understand the pathophysiology of Lowe syndrome.This publication has 32 references indexed in Scilit:
- Phosphoinositide profiling in complex lipid mixtures using electrospray ionization mass spectrometryNature Biotechnology, 2003
- Human RhoGAP domain‐containing proteins: structure, function and evolutionary relationshipsFEBS Letters, 2002
- Phosphoinositides : key players in cell signalling, in time and spaceCellular Signalling, 2001
- Ocrl1, a PtdIns(4,5)P25-Phosphatase, Is Localized to theTrans-Golgi Network of Fibroblasts and Epithelial CellsJournal of Histochemistry & Cytochemistry, 2000
- Phosphatidylinositol 4,5-Bisphosphate Functions as a Second Messenger that Regulates Cytoskeleton–Plasma Membrane AdhesionCell, 2000
- Increased levels of plasma lysosomal enzymes in patients with Lowe syndromeProceedings of the National Academy of Sciences of the United States of America, 1999
- Cell Lines from Kidney Proximal Tubules of a Patient with Lowe Syndrome Lack OCRL Inositol Polyphosphate 5-Phosphatase and Accumulate Phosphatidylinositol 4,5-BisphosphatePublished by Elsevier BV ,1998
- Lowe Syndrome, a deficiency of a phosphatidyl-inositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatusHuman Molecular Genetics, 1995
- The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.Proceedings of the National Academy of Sciences of the United States of America, 1995
- The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphataseNature, 1992